Quantcast

Latest Cardiac PET Stories

2010-11-10 03:30:00

DALLAS, November 10, 2010 /PRNewswire/ -- The report analyzes the PET SPECT Market ( http://www.marketsandmarkets.com/Market-Reports/pet-market-98.html) by technologies and applications and studies the major market drivers, restraints, and opportunities for the PET SPECT market in U.S., EMEA, and Asia-Pacific. Browse market data tables and in-depth TOC on Advanced PET (Positron Emission Tomography) & SPECT (Single Photon Emission Computed Tomography) Global Market (2010 -2015)...

2010-03-11 06:45:00

MOUNTAIN VIEW, Calif., March 11 /PRNewswire/ -- Based on its recent analysis of the cardiac molecular imaging systems market, Frost & Sullivan recognizes Positron Corporation with the 2010 North American Award for New Product Innovation, for its pioneering cardiac positron emission tomography (PET) scanner, Attrius(TM). The Attrius(TM) was developed and optimized for molecular imaging of the heart, making it the ideal solution for cardiologists and hospitals looking to add high...

2009-06-15 11:31:18

Combined high-definition PET and "motion-frozen" technology can greatly advance heart imaging, say researchers at SNM's 56th Annual MeetingCombining high-definition positron emission tomography (PET) and "motion-frozen" technology provides enhanced cardiac images. The motion-frozen technology adds physiological details that were previously invisible to physicians, according to researchers at SNM's 56th Annual Meeting in Toronto. A new study of the combined technologies shows that the method...

2008-07-23 12:01:24

BOSTON, July 23 /PRNewswire/ -- FluoroPharma Inc., a company developing breakthrough molecular imaging agents for the Positron Emission Tomography (PET) market, announced positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical development. BFPET is a PET imaging agent, designed to assess the blood flow in the heart (myocardial perfusion). Myocardial...

2008-07-23 12:01:24

QuantRx(R) Biomedical Corporation (OTCBB:QTXB), a broad-based diagnostics company focused on the development and commercialization of innovative diagnostic products based on its patented technology platforms for the worldwide healthcare industry, today announced that QuantRx's FluoroPharma has achieved positive Phase I results for BFPET, its novel Fluorine-18 labeled tracer for myocardial perfusion imaging. BFPET is FluoroPharma's second cardiovascular product to complete Phase I clinical...

ca66d345fe12515a8b34b15a3b0f60401
2005-11-30 17:00:00

By Susan Kelly CHICAGO -- The promise of faster, less-invasive disease detection and treatment is expanding the use of medical imaging among physicians and generating healthy returns for manufacturers of the pricey equipment. High-speed CT scanners that can construct a precise picture of the heart in five heartbeats are moving beyond radiology departments to emergency rooms and cardiac labs to help diagnosis and manage coronary artery disease, company executives and physicians said this week...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related